Sponsor or institution

Clinical trials and research at MedSIR

• 6Clinical trials
• 13Countries

Newest trials

All recruiting trials (6)

• Bexmarilimab with doxorubicin for metastatic soft-tissue sarcoma

  This study tests whether adding bexmarilimab to doxorubicin is safe and helps people with metastatic soft-tissue sarcoma.

  Recruiting at 5 sites Phase 1/2 MedSIR · Badalona and 10 other locations · NCT07460986

• Combination of Camizestrant and Ribociclib in HR+ Breast Cancer

  This study tests whether the combo of camizestrant and ribociclib can help people with HR+ breast cancer who have already had endocrine therapy to delay disease progression.

  Recruiting at 8 sites Phase 2 MedSIR · Dessau and 15 other locations · NCT07195227

• Trastuzumab deruxtecan versus CDK4/6 inhibitor plus hormone therapy as first-line treatment for HR-positive, HER2-low non-luminal advanced breast cancer.

  This trial will see if trastuzumab deruxtecan (T-DXd) works better than a CDK4/6 inhibitor plus endocrine (hormone) therapy as first-line treatment for adults with HR-positive, HER2-low advanced breast cancer that is classified as non-luminal by gene profiling.

  Recruiting at 79 sites Phase 2 MedSIR · Graz and 78 other locations · NCT06486883

• Combination treatment for advanced ER-positive breast cancer with ESR1 mutations

  This study is testing if a new combination of two drugs can help people with advanced ER-positive breast cancer that has specific mutations live longer and keep their cancer under control.

  Recruiting at 81 sites Phase 3 MedSIR · Innsbruck and 103 other locations · NCT06382948

• Repotrectinib for treating ROS1-positive lung cancer with brain metastasis

  This study is testing a new drug called repotrectinib to see if it can help people with ROS1-positive lung cancer that has spread to the brain.

  Recruiting at 17 sites Phase 2 MedSIR · Graz and 16 other locations · NCT06315010

• Niraparib treatment after surgery for ovarian cancer patients with limited metastasis

  This study is testing if a medication called niraparib can help women with certain types of ovarian cancer live longer without their cancer getting worse after surgery.

  Recruiting at 14 sites Phase 2 MedSIR · A Coruña and 13 other locations · NCT06180356

Quick answers

How many clinical trials run by MedSIR are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 13 countries. The most sites are in Spain (6 trials), Germany (4 trials), Austria (3 trials), France (2 trials), Italy (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 4, Phase 1/2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →